Taken together, the IL-6/JAK/STAT3 pathway is a major regulator of breast cancer metastasis through promoting breast cancer cell proliferation, EMT, enriching the breast CSCs, and suppressing apoptosis. Here, IL6 is linked to breast carcinoma.